MARÍA CONSUELO DEL
CAÑIZO FERNÁNDEZ-ROLDÁN
Investigadora en el periodo 1993-2017
Elisa
Luño Fernández
Publicaciones en las que colabora con Elisa Luño Fernández (16)
2015
-
Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: Results from the Spanish registry
Leukemia, Vol. 29, Núm. 9, pp. 1875-1881
-
Use of newer prognostic indices for patients with myelodysplastic syndromes in the low and intermediate-1 risk categories: A population-based study
The Lancet Haematology, Vol. 2, Núm. 6, pp. e260-e266
2014
-
Multivariate time-dependent comparison of the impact of lenalidomide in lower-risk myelodysplastic syndromes with chromosome 5q deletion
British Journal of Haematology, Vol. 166, Núm. 2, pp. 189-201
-
Role of minimal residual disease and chimerism after reduced-intensity and myeloablative allo-transplantation in acute myeloid leukemia and high-risk myelodysplastic syndrome
Leukemia Research, Vol. 38, Núm. 5, pp. 551-556
-
Transfusion dependence development and disease evolution in patients with MDS and del(5q) and without transfusion needs at diagnosis
Leukemia Research, Vol. 38, Núm. 3, pp. 304-309
2013
-
Complex, not monosomal, karyotype is the cytogenetic marker of poorest prognosis in patients with primary myelodysplastic syndrome
Journal of Clinical Oncology, Vol. 31, Núm. 7, pp. 916-922
2012
-
Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndrome
Cancer, Vol. 118, Núm. 1, pp. 127-133
-
Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromes
British Journal of Haematology, Vol. 159, Núm. 3, pp. 311-321
-
The degree of neutropenia has a prognostic impact in low risk myelodysplastic syndrome
Leukemia Research, Vol. 36, Núm. 3, pp. 287-292
2011
-
Clinical impact of the clone size in MDS cases with monosomy 7 or 7q deletion, trisomy 8, 20q deletion and loss of Y chromosome
Leukemia Research, Vol. 35, Núm. 6, pp. 834-836
-
Cytogenetic risk stratification in chronic myelomonocytic leukemia
Haematologica, Vol. 96, Núm. 3, pp. 375-383
-
Evaluation of tolerability and efficacy of imatinib mesylate in elderly patients with chronic phase CML: ELDERGLI study
Leukemia Research, Vol. 35, Núm. 9, pp. 1184-1187
-
Prognostic impact of severe thrombocytopenia in low-risk myelodysplastic syndrome
Cancer, Vol. 117, Núm. 24, pp. 5529-5537
2009
-
C005 Prognostic impact of the proportion of aberrant metaphases in patients with a primary myelodysplastic syndrome
Leukemia Research, Vol. 33, Núm. SUPPL. 1
-
P029 Prognostic relevance of specific chromosomal abnormalities in chronic myelomonocytic leukemia
Leukemia Research, Vol. 33, Núm. SUPPL. 1
-
P030 Prognostic impact on survival of an unsuccessful conventional cytogenetic study in patients with myelodysplastic syndromes (MDS)
Leukemia Research, Vol. 33, Núm. SUPPL. 1